SilverStream solution
Commercial- Indications
- Wound cleansing, Wound healing
Company intelligence / Profile preview
EnzySurge develops proprietary wound care platforms focused on chronic wound management. Its flagship product line, DermaStream, uses patented Continuous Streaming Therapy to deliver a continuous supply of therapeutic solutions throughout all phases of the wound healing process. The company’s SilverStream product combines silver ions with other agents in a hypertonic solution to clean and treat hard-to-heal wounds. Clinical studies have demonstrated safety and efficacy in selective debridement and accelerated closure of chronic wounds. The company has received FDA clearance for its main device/platform.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EnzySurge.